Alignment Healthcare, Inc.ALHC

Alignment Healthcare, Inc. (ALHC) is a Medicare-focused health plan and care-delivery company whose latest 10-Q shows revenues of $1.24bn for the quarter ending 31 March 2026, net income of $11.4m, and an operating income of $15.5m, all of which are modestly positive but not exactly eye-watering for a company with a $1.26bn asset base. The business still burns more cash on operations than it generates in free cash flow, with $128.7m provided by operating activities offset by $7.4m in capital spending-figures that sit closer to a lean start-up than a scaled healthcare giant.

Alignment’s core pitch is a technology-enabled care model (AVA®) that it claims drives better outcomes for seniors while supposedly bending the cost curve. The company leans heavily on awards-including a 2022 ACG Innovation Award for AVA®-and CMS star ratings of at least 3.5 stars, but the filings and public pages do not disclose utilisation volumes, customer acquisition costs, or the per-member economics that would let outsiders judge whether the model is actually working.

The balance sheet is the one place that looks healthy: $705.6m in cash and near-cash against $1.05bn in liabilities leaves shareholders’ equity at $206.9m. Diluted EPS for the quarter came in at $0.05 on 213.1m shares, which is either a rounding error or a testament to how thin the company’s profit margins are. Management’s latest filing notes “leadership updates” designed to “strengthen the organisation as the company continues to scale,” but the only concrete changes are personnel moves: a new chairman and a vice-chairman-cum-EVP of Corporate Affairs.

The company’s newsroom and blog pages trumpet the Fortune brand in their footers, but it’s a disclaimer, not an endorsement-Fortune Media IP Limited explicitly states it is not affiliated with Alignment Healthcare. The visuals and copy are polished, but the filings are the only place where the numbers don’t lie. Alignment’s reported numbers are real; the customer economics and platform utilisation that would explain them are not.

The company’s operating cash flow of $128.7m is a bright spot, but it is still below the level needed to fund growth without additional capital, especially given the $7.4m spent on property, plant, and equipment in the same period. The board’s recent shuffle suggests a pivot toward “disciplined execution,” which in practice likely means tighter capital discipline and slower expansion until the unit economics improve. What the filings cannot tell us is how many members are enrolled, what the churn rate is, or whether the AVA® platform is truly driving the touted cost savings.

For readers who want a quick sense of the company’s operating rhythm, the 10-Q is the only place to look-everything else is marketing. The filings show a cash-rich balance sheet propping up modest profitability, while the rest is narrative. If you want to know whether the model is sustainable, you’ll need member-level utilisation data that the company has not yet disclosed.